Bruker Corporation (NASDAQ:BRKR) Given Consensus Recommendation of "Hold" by Analysts

Key Points

• Analysts have a consensus “Hold” rating on Bruker, with six buys, five holds, two sells and one strong buy among 14 brokerages. The average 12-month price target is $57.00.
• Bruker reported quarterly EPS of $0.49, beating the $0.38 consensus estimate, while revenue of $838.5 million fell short of expectations but increased 5.2% year over year. The company reaffirmed fiscal 2026 EPS guidance of $2.10–$2.15.
• Shares opened at $53.43, below the analyst average target, and institutional investors own 79.52% of the stock. Bruker also declared a quarterly dividend of $0.05, equivalent to a 0.4% annual yield.

Bruker Corporation (NASDAQ:BRKR - Get Free Report) has been assigned an average recommendation of "Hold" from the fourteen brokerages that are covering the company, MarketBeat.com reports. Two analysts have rated the stock with a sell recommendation, five have assigned a hold recommendation, six have issued a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12 month target price among analysts that have covered the stock in the last year is $57.00.

A number of research analysts have weighed in on BRKR shares. TD Cowen reiterated a "hold" rating on shares of Bruker in a research note on Wednesday, July 15th. Weiss Ratings reiterated a "sell (d+)" rating on shares of Bruker in a research note on Monday, August 31st. JPMorgan Chase & Co. increased their target price on Bruker from $55.00 to $65.00 and gave the stock an "overweight" rating in a research report on Monday, June 8th. Stifel Nicolaus set a $50.00 price target on Bruker in a report on Wednesday, August 5th. Finally, Zacks Research cut Bruker from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, September 2nd.

Institutional Trading of Bruker

Several institutional investors and hedge funds have recently bought and sold shares of the company. Los Angeles Capital Management LLC bought a new stake in shares of Bruker during the 4th quarter valued at about $26,000. Allworth Financial LP increased its position in shares of Bruker by 40.6% in the third quarter. Allworth Financial LP now owns 890 shares of the medical research company's stock worth $29,000 after purchasing an additional 257 shares during the last quarter. Essential Partners LLC purchased a new stake in Bruker in the first quarter valued at approximately $36,000. Global Retirement Partners LLC purchased a new stake in Bruker in the second quarter valued at approximately $38,000. Finally, Parallel Advisors LLC lifted its position in Bruker by 121.0% during the fourth quarter. Parallel Advisors LLC now owns 875 shares of the medical research company's stock valued at $41,000 after purchasing an additional 479 shares during the last quarter. 79.52% of the stock is currently owned by hedge funds and other institutional investors.

Bruker Price Performance

BRKR stock opened at $53.43 on Monday. The company's fifty day simple moving average is $58.25 and its 200 day simple moving average is $49.32. Bruker has a 12-month low of $30.09 and a 12-month high of $65.30. The firm has a market cap of $8.14 billion, a price-to-earnings ratio of -76.33, a PEG ratio of 1.63 and a beta of 1.26. The company has a quick ratio of 0.92, a current ratio of 1.85 and a debt-to-equity ratio of 0.76.

Bruker (NASDAQ:BRKR - Get Free Report) last announced its quarterly earnings data on Tuesday, August 4th. The medical research company reported $0.49 EPS for the quarter, beating analysts' consensus estimates of $0.38 by $0.11. The firm had revenue of $838.50 million during the quarter, compared to analysts' expectations of $853.57 million. Bruker had a positive return on equity of 12.47% and a negative net margin of 2.35%.The company's revenue for the quarter was up 5.2% compared to the same quarter last year. During the same quarter last year, the firm posted $0.32 earnings per share. Bruker has set its FY 2026 guidance at 2.100-2.150 EPS. On average, analysts expect that Bruker will post 2.12 earnings per share for the current year.

Bruker Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 7th. Stockholders of record on Monday, September 21st will be given a $0.05 dividend. This represents a $0.20 dividend on an annualized basis and a dividend yield of 0.4%. The ex-dividend date is Monday, September 21st. Bruker's dividend payout ratio (DPR) is -28.57%.

Bruker Company Profile

Bruker Corporation develops and manufactures scientific instruments, analytical systems and software used to study the chemical, physical and biological properties of materials. Its customers include universities, pharmaceutical and biotechnology companies, industrial manufacturers, hospitals, government laboratories and other research organizations.

The company's product portfolio includes nuclear magnetic resonance and electron paramagnetic resonance systems, mass spectrometers, X-ray analysis instruments, optical and molecular spectroscopy systems, microscopy and nanoanalysis tools, and instruments for microbiology and spatial biology.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.